AzTrials
AzTrials

Upper Extremity InjuryNCT07278791

Survey-Based Study on Recovery Period Differences in Upper Extremity Injuries Among Indoor Climbers by Treatment Method

An observational study of Upper Extremity Injury, run by Sahmyook University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate the differences in recovery periods of upper extremity injuries among indoor climbers according to their treatment methods. The research focuses on comparing the recovery duration, specifically the time to return to climbing, between those who received professional physical therapy and… Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Upper Extremity Injury
Type of treatment
Injection or infusion
How many people
300 participants
Where
No sites listed yet
Study dates
1 Dec 2025to 30 Apr 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: This study will include indoor climbers aged 18 to 50 who experienced an upper extremity injury related to climbing within the past 12 months and received any form of treatment. Participants will be recruited from climbing communities, gyms, and online platforms. Only non-professional climbers will be included to ensure generalizability to the general indoor climbing population.

Who may be able to join

  • Adults aged 18-50 years.
  • Individuals who have participated in indoor climbing within the past 12 months.
  • Individuals who have experienced an upper extremity injury (e.g., finger, wrist, elbow, shoulder; tendonitis, ligament injury, muscle tear) during indoor climbing within the past 12 months.
  • Individuals who received any form of treatment (self-care, physical therapy, injection, surgery, rehabilitation exercise) for the injury.
  • Individuals who can provide informed consent and complete an online questionnaire.

Who cannot join

  • Individuals who underwent major orthopedic surgery or fracture-related surgery unrelated to climbing.
  • Individuals who required hospitalization or long-term inpatient treatment (>3 months) due to severe musculoskeletal conditions.
  • Individuals currently receiving ongoing treatment for the same injury.
  • Individuals with neurological, systemic, or medical conditions that significantly affect musculoskeletal recovery.
  • Climbing coaches, professional climbers, or clinicians providing treatment (to avoid expert bias).

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Changyong Choi, PT, MPT Candidate contact

+82-10-7184-3782

libetoi2@naver.com

Seungwon Lee, PhD, PT contact

+82-2-3399-1638

swl@syu.ac.kr

About this study

Official title: A Survey-Based Study on Differences in Recovery Periods of Upper Extremity Injuries Among Indoor Climbers According to Treatment Methods

This study aims to investigate the differences in recovery periods of upper extremity injuries among indoor climbers according to their treatment methods.

The research focuses on comparing the recovery duration, specifically the time to return to climbing, between those who received professional physical therapy and those who relied on self-treatment or other conservative management.

Read more

Additionally, this survey-based observational study seeks to explore how individual and training-related factors - such as warm-up duration, climbing frequency, and years of experience - affect the occurrence and recurrence of upper extremity injuries.

Participants will complete an online questionnaire consisting of demographic data, climbing habits, injury characteristics, treatment methods, and recovery outcomes.

The data will be collected anonymously and analyzed to determine whether the type of treatment correlates with faster recovery or reduced reinjury risk.

The findings are expected to provide foundational evidence for developing effective rehabilitation and injury-prevention strategies for indoor climbers, and to guide clinicians and trainers in selecting appropriate treatment approaches for upper extremity injuries.

Read the detailed description

This cross-sectional survey will recruit indoor climbers aged 18-50 who have experienced upper extremity injuries within the past 12 months.

The questionnaire includes sections on injury site and type (e.g., finger, wrist, elbow, shoulder; tendonitis, ligament injury, or muscle tear), treatment method (self-care, physical therapy, injection, surgery, or rehabilitation exercise), treatment duration, and perceived recovery status.

Statistical analysis will be performed to compare mean recovery periods among treatment groups and to examine correlations with demographic and behavioral factors.

The study was approved by the Institutional Review Board of Sahmyook University (IRB No. 2025-06-034-002).

Results from this research may contribute to improved understanding of injury management and evidence-based rehabilitation for indoor climbers.

Keywords
Indoor Climbing, Bouldering, Physical Therapy, Self-Treatment, Rehabilitation, Injury Recovery, Upper Limb, Sports Injury
Medical subject headings
Arm Injuries, Athletic Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07278791
Study groupRoleWhat they receive
Self-Treatment GroupParticipants who treated their upper extremity injury through self-managed care such as rest, cold/heat therapy, taping, or over-the-counter medication.
Physical Therapy GroupParticipants who received professional non-surgical physical therapy, including manual therapy, therapeutic exercise, or extracorporeal shockwave therapy.
Injection Therapy GroupParticipants who received non-surgical injection treatments such as prolotherapy, PRP, or steroid injections for upper extremity injury.
Surgery/Rehabilitation GroupParticipants who underwent surgical or invasive procedures followed by rehabilitation or exercise-based recovery programs.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Recovery Duration (Weeks) According to Treatment Type

    The average number of weeks required for indoor climbers to achieve full recovery and return to climbing after upper extremity injury, compared across treatment types (self-care, physical therapy, injection, surgery/rehabilitation).

    Measured: 12 months (retrospective survey)

Secondary outcomes (3)
  1. Reinjury Rate Within 12 Months

    Proportion of indoor climbers who experienced a recurrent upper-extremity injury in the same anatomical region within the past 12 months.

    Measured: 12 months

  2. Pain Resolution Duration (Weeks)

    Number of weeks required for complete pain resolution after upper-extremity injury, based on participant recall.

    Measured: 12 months (retrospective survey)

  3. Return-to-Climbing Criteria (Self-Reported)

    Self-reported criteria participants used to determine readiness to resume climbing after upper-extremity injury (e.g., full pain resolution, daily activity tolerance, strength recovery).

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2025
  2. Study start1 Dec 2025 (estimated)
  3. Primary completion28 Feb 2026 (estimated)
  4. Study completion30 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07278791
Sponsor's protocol ID
2025-06-034-002
Status last verified
Nov 2025
First submitted
1 Dec 2025
Last updated
12 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This study does not collect individual participant data (IPD) such as raw clinical data or identifiable records. All survey responses are anonymized, aggregated, and analyzed at the group level. Therefore, there is no IPD available to share.

Publications

  • Schoffl V, Popp D, Kupper T, Schoffl I. Injury trends in rock climbers: evaluation of a case series of 911 injuries between 2009 and 2012. Wilderness Environ Med. 2015 Mar;26(1):62-7. doi: 10.1016/j.wem.2014.08.013.

    PubMed 25712297

Questions about this trial

What is this clinical trial studying?

An observational study of Upper Extremity Injury, run by Sahmyook University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Changyong Choi, PT, MPT Candidate (+82-10-7184-3782, libetoi2@naver.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean Recovery Duration (Weeks) According to Treatment Type (time frame: 12 months (retrospective survey)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07278791, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in